Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Temin

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
JCO Oncology Practice|May 22, 2024
Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS StandardsRobert D Siegel, Kristine B LeFebvre, Sarah Temin, et al.
JCO Global Oncology|January 11, 2024
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified GuidelineSana Al Sukhun, Sarah Temin, Carlos H Barrios, et al.
JCO Global Oncology|August 27, 2025
Geriatric Assessment: ASCO Global GuidelineCristiane Decat Bergerot, Sarah Temin, Haydee C Verduzco-Aguirre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Bryan J Schneider, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2021
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Andrew G Robinson, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
JCO Oncology Practice|May 22, 2024
Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS StandardsRobert D Siegel, Kristine B LeFebvre, Sarah Temin, et al.
JCO Global Oncology|January 11, 2024
Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified GuidelineSana Al Sukhun, Sarah Temin, Carlos H Barrios, et al.
JCO Global Oncology|August 27, 2025
Geriatric Assessment: ASCO Global GuidelineCristiane Decat Bergerot, Sarah Temin, Haydee C Verduzco-Aguirre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2020
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Bryan J Schneider, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2021
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateNasser H Hanna, Andrew G Robinson, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living GuidelineNavneet Singh, Sarah Temin, Sherman Baker, et al.
Pageof 8